Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.79%
1,109.26
+8.65
+0.79%
—1,100.611,106.151,114.281,106.15——
SIXC
Communications
SIXC
Communications
SIXC
+0.38%
614.65
+2.35
+0.38%
—612.30612.30616.16612.30——
SIXE
Energy
SIXE
Energy
SIXE
+1.45%
1,192.45
+17.11
+1.45%
—1,175.461,182.971,193.951,182.97——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.62%
1,739.79
+10.67
+0.62%
—1,729.121,731.371,754.071,731.37——
SIXM
Financials
SIXM
Financials
SIXM
+0.36%
647.02
+2.29
+0.36%
—644.73645.31647.88643.80——
SIXR
Staples
SIXR
Staples
SIXR
+0.56%
831.73
+4.64
+0.56%
—827.09828.05832.16828.04——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.28%
215.43
+0.61
+0.28%
—214.82214.82216.61214.82——
SIXT
Technology
SIXT
Technology
SIXT
+0.74%
3,138.36
+23.19
+0.74%
—3,115.173,142.773,151.703,133.07——
SIXU
Utilities
SIXU
Utilities
SIXU
+1.04%
919.89
+9.46
+1.04%
—910.43915.18923.94915.18——
SIXV
Health care
SIXV
Health care
SIXV
+0.88%
1,487.41
+12.91
+0.88%
—1,474.501,480.841,489.101,480.84——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.37%
2,414.74
+8.87
+0.37%
—2,405.872,415.572,417.292,407.56——
M1RN34:BVMF
Moderna Inc Bdr
R$13.49
+0.67%
(+0.090) 1D
Apr 22, 10:44:36 AM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for M1RN34...
Open
R$13.54
High
R$13.74
Low
R$13.49
Mkt. cap
21.82B
Avg. vol.
42.84K
Volume
489.00
52-wk high
R$15.53
52-wk low
R$6.02
Shares outstanding
396.59M
No. of employees
5K
News stories
From sources across the web
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern". The company's commercial products are the Moderna COVID-19 vaccine, marketed as Spikevax and a respiratory syncytial virus vaccine, marketed as Mresvia. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines. Wikipedia
About Moderna Inc Bdr
CEOStéphane Bancel
Employees4.7K
FoundedSep 2010
Headquarters-
SectorBiotechnology
Websitemodernatx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
108.00M
142.00M
1.02B
678.00M
Cost of goods sold
946.00M
819.00M
1.01B
1.23B
Cost of revenue
946.00M
819.00M
1.01B
1.23B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
212.00M
230.00M
268.00M
308.00M
Operating expense
212.00M
230.00M
268.00M
308.00M
Total operating expenses
1.16B
1.05B
1.28B
1.54B
Operating income
-1.05B
-907.00M
-260.00M
-857.00M
Other non operating income
4.00M
9.00M
-4.00M
-2.00M
EBT including unusual items
-964.00M
-818.00M
-187.00M
-799.00M
EBT excluding unusual items
-957.00M
-818.00M
-191.00M
-797.00M
Income tax expense
7.00M
7.00M
13.00M
27.00M
Effective tax rate
-0.73%
-0.86%
-6.95%
-3.38%
Other operating expenses
-
-
-
-
Net income
-971.00M
-825.00M
-200.00M
-826.00M
Net profit margin
-899.07%
-580.99%
-19.68%
-121.83%
Earnings per share
-2.52
-2.13
-0.51
-2.11
Interest and investment income
90.00M
81.00M
73.00M
70.00M
Interest expense
-1.00M
-1.00M
-
-8.00M
Net interest expenses
89.00M
80.00M
73.00M
62.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.01B
-850.00M
-208.00M
-790.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer